National and Kapodistrian University of Athens
Ορμονικές προσαρμογές που ακολουθούν την απώλεια βάρους μέσω της βαριατρικής χειρουργικής
Abstract
dc:descriptionBackground and aims: Bariatric surgery, the most effective method for the long-term treatment of morbid obesity, exerts beneficial effects on glucose metabolism. The possible underlying mechanisms include massive loss of fat mass, restricted caloric intake and changes in gut hormones. The aim of our study was to compare the effects of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) on glucose, insulin resistance, as well as ghrelin, PYY and GLP-1 levels.Materials and methods: Twenty-eight morbidly obese patients were consecutively recruited, of which 11 underwent RYGB (age: 38.6±8.2 years; BMI: 48±6 kg/m2), and 17 SG (age: 41.3±8.1 years; BMI: 50.7±7.3 kg/m2, p=NS vs RYGB). They were examined preoperatively, as well as 3, 6, and 12 months after surgery. Blood samples were drawn before, and 30, 60, 90, 120, 150 and 180 min after consumption of a mixed meal for the measurement of glucose, insulin, triglycerides, ghrelin, PYY and GLP-1. Insulin resistance was estimated with the HOMA-IR index. Postprandial responses were expressed as area under the curve (AUC).Results: There were no preoperative differences between groups in any of the parameters. Both experienced significant and comparable weight loss postoperatively. Amelioration of glucose metabolism, as well as reduction of insulin resistance was observed after both surgeries. RYGB had a beneficial effect in terms of lipid metabolism when compared with SG. Fasting ghrelin levels decreased after SG (Ghrelin_preop_SG: 223.2±77 vs 3months: 129.3±20.9, 6months: 106.4±15.8, 12months: 128±19.8 pg/mL, all p<0.02 vs preop), while they were increased at 12 months (p=0.04 vs preop) after RYGB. Ghrelin postprandial response was decreased significantly at 6 and 12 months after SG (both p<0.01), with nonsignificant changes after RYGB. Postprandial PYY response was increased at 3, 6, and 12 months after RYGB (PYY_AUC_preop_RYGB: 11406.7±4593.9 vs 3months: 19187.4±5617.5, 6months: 22405.8±8259.2, 12months: 24940.6±9399.1 pg•min/mL, all p≤0.02), and only at 3 months after SG (p=0.016). Finally, postprandial GLP-1 levels were significantly higher in the RYGB group compared to that after SG at 6 months (GLP-1_AUC_6months_RYGB: 9966±2137.9 vs SG: 7507.7±3011.1 pM•min, p=0.046). Lipidemic profil was reduced only after RYGB.Conclusion: RYGB and SG induce distinctly differing gut hormone responses, the first leading to a pronounced increase in PYY, and the second to a decrease in ghrelin. However, the satiety-inducing effects of both lead to comparable effects on weight loss, glucose dynamics, and insulin sensitivity. It seems that weight loss per se is the primary driving force behind these metabolic improvements, while gut hormones play a secondary role. RYGB exerts also a beneficial effect in terms of fasting and postprandial lipidemia.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Liaskos, Christos
- Λιάσκος, Χρήστος
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44892